ANICARE
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ANICARE Trademark

Serial Number: 97523042

ANICARE is a trademark filed by CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd. on July 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd. (4 trademarks)

Unit 301, 6399 Hutai Road
Baoshan, Shanghai 201908 , CN

Entity Type: 99

Trademark Details

Filing Date

July 27, 2022

Registration Date

Not Registered

Goods & Services

pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 6, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 6, 2024 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 7, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 7, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 7, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 7, 2024 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 18, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 18, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 18, 2024 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 5, 2024 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 12, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 12, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 12, 2023 CNSL
ASSIGNED TO EXAMINER
May 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2022 NWOS
NEW APPLICATION ENTERED
Jul 30, 2022 NWAP